Developing animal models for pediatric HIV prevention products
Official title: Participation in a Workshop on Development of Animal Models Supporting Pediatric Formulation Development
Funded at Advanced Bioscience Laboratories, INC. · NIH-11142351 · Data updated 2026-11-12
This study is working on developing safe and effective treatments and prevention methods for children at risk of HIV, and it involves scientists teaming up to make sure these new options are ready for testing and approval.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $253,411 |
| NIH project number | 75N93023D00001-0-759302400004-1 |
| Project ID | NIH-11142351 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children and adolescents who are at risk of HIV or involved in HIV prevention programs.
✕Less likely to help
Patients who are not at risk for HIV or who are adults may not receive direct benefits from this research.
What this research studies
This research focuses on creating and refining animal models that will aid in the development of medications and prevention strategies specifically for children at risk of HIV. The project involves collaboration with various scientific and academic partners to ensure that the formulations are safe and effective for pediatric use. By participating in workshops, researchers will discuss and plan the necessary steps to advance these products towards clinical testing and eventual approval. The goal is to fill gaps in current research and expedite the development of new therapies and prevention methods for HIV in young populations.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective HIV prevention products specifically designed for children and adolescents.
How similar studies have gone: Previous research has shown success in developing pediatric formulations for other diseases, indicating a promising potential for this approach in HIV prevention.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.